2m 2m 2m 2m 2m 2m 2m
Pacira BioScienc (PCRX)
NASDAQ
$24.66-$0.01 (-0.04%)
Price as of Aug 21, 2026 6:29 PM EDT- $983.4MMarket Cap
- -4.53%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Pacira BioScienc (PCRX)
$24.66-$0.01 (-0.04%)
PCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.67 | ||
Change | +$0.84 (+3.52%) | ||
Open | $23.91 | ||
High | $24.72 | ||
Low | $23.66 | ||
Previous Close | $23.83 | ||
Volume | 475,872 | ||
30-Day Average Volume | 687,682 | ||
1-Week Change | 7.26% | ||
1-Month Change | -4.31% | ||
1-Year Change | -4.53% | ||
3-Year Change | -34.68% | ||
5-Year Change | -56.27% | ||
Fundamentals | |||
Shares Outstanding | 39.9M | ||
Total Assets | $1.2B | ||
Market Cap | $983.4M | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | $190.5M | ||
Net Income | $4.7M | ||
Free Cash Flow | $56.1M | ||
EBIT | $6.2M | ||
EBITDA | $27.5M | ||
Net Working Capital | $493.2M | ||
EPS | $0.12 | ||
Enterprise Value/EBITDA | 44 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | 206 | ||
PEG | 3 | ||
Price/Free Cash Flow | 18 | ||
Price/Operating Cash Flow | 17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue